A recent New York Times story described a new fad: "microdosing" GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) ...

Experts are divided on the subject, however. While some suggest that even small doses of Ozempic could suppress appetite, there is little scientific data to support claims that microdosing leads to ...

The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and ...